4.5 Review

Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects

期刊

AMERICAN HEART JOURNAL
卷 163, 期 6, 页码 912-930

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.ahj.2012.02.023

关键词

-

向作者/读者索取更多资源

This White Paper, written collaboratively by members of the Cardiac Safety Research Consortium from academia, industry, and regulatory agencies, discusses different methods to characterize the QT effects for drugs that have a substantial direct or indirect effect on heart rate. Descriptions and applications are provided for individualized QT-R-R correction, Holter bin, dynamic QT beat-to-beat, pharmacokinetic-pharmacodynamic modeling, and QT assessment at constant heart rate. Most of these techniques are optimally performed using continuous electrocardiogram data obtained in clinical studies designed to characterize a drug's effect on the QT interval. An important study design element is the collection of drug-free data over a range of heart rates seen on treatment. The range of heart rates is increased at baseline by using ambulatory electrocardiogram recordings in addition to those collected under semisupine, resting conditions. Discussions in this study summarize areas of emerging consensus and other areas in which consensus remains elusive and provide suggestions for additional research to further increase our knowledge and understanding of this topic. (Am Heart J 2012;163:912-30.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Scientific white paper on concentration-QTc modeling

Christine Garnett, Peter L. Bonate, Qianyu Dang, Georg Ferber, Dalong Huang, Jiang Liu, Devan Mehrotra, Steve Riley, Philip Sager, Christoffer Tornoe, Yaning Wang

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2018)

Article Pharmacology & Pharmacy

Study Design Parameters Affecting Exposure Response Analysis of QT Data: Results From Simulation Studies

Georg Ferber, Yaning Sun, Borje Darpo, Christine Garnett, Jiang Liu

JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Article Public, Environmental & Occupational Health

Implications of Individual QT/RR Profiles-Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes

Marek Malik, Christine Garnett, Katerina Hnatkova, Jose Vicente, Lars Johannesen, Norman Stockbridge

DRUG SAFETY (2019)

Article Public, Environmental & Occupational Health

Implications of Individual QT/RR Profiles-Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections

Marek Malik, Christine Garnett, Katerina Hnatkova, Jose Vicente, Lars Johannesen, Norman Stockbridge

DRUG SAFETY (2019)

Article Pharmacology & Pharmacy

Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study

Jose Vicente, Robbert Zusterzeel, Lars Johannesen, Roberto Ochoa-Jimenez, Jay W. Mason, Carlos Sanabria, Sarah Kemp, Philip T. Sager, Vikram Patel, Murali K. Matta, Jiang Liu, Jeffry Florian, Christine Garnett, Norman Stockbridge, David G. Strauss

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Correction Public, Environmental & Occupational Health

Implications of Individual QT/RR Profiles-Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections (vol 42, pg 401, 2019)

Marek Malik, Christine Garnett, Katerina Hnatkova, Jose Vicente, Lars Johannesen, Norman Stockbridge

DRUG SAFETY (2019)

Correction Public, Environmental & Occupational Health

Implications of Individual QT/RR Profiles-Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc Changes (vol 42, pg 415, 2019)

Marek Malik, Christine Garnett, Katerina Hnatkova, Jose Vicente, Lars Johannesen, Norman Stockbridge

DRUG SAFETY (2019)

Editorial Material Cardiac & Cardiovascular Systems

New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017

Cecile Ollivier, Haihao Sun, Wayne Amchin, Maurice Beghetti, Rolf M. F. Berger, Stefanie Breitenstein, Christine Garnett, Ninna Gullberg, Patrik Hassel, Dunbar Ivy, Steven M. Kawut, Agnes Klein, Catherine Lesage, Marek Migdal, Barbara Nije, Michal Odermarsky, James Strait, Pieter A. de Graeff, Norman Stockbridge

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)

Article Physiology

Errors of Fixed QT Heart Rate Corrections Used in the Assessment of Drug-Induced QTc Changes

Katerina Hnatkova, Jose Vicente, Lars Johannesen, Christine Garnett, Norman Stockbridge, Marek Malik

FRONTIERS IN PHYSIOLOGY (2019)

Article Physiology

Detection of T Wave Peak for Serial Comparisons of JTp Interval

Katerina Hnatkova, Jose Vicente, Lars Johannesen, Christine Garnett, David G. Strauss, Norman Stockbridge, Marek Malik

FRONTIERS IN PHYSIOLOGY (2019)

Review Pharmacology & Pharmacy

Redefining Blood Pressure Assessment - The Role of the Ambulatory Blood Pressure Monitoring Study for Drug Safety

Christine Garnett, Lars Johannesen, Tzu-Yun McDowell

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

Article Multidisciplinary Sciences

Heart Rate Correction of the J-to-Tpeak Interval

Katerina Hnatkova, Jose Vicente, Lars Johannesen, Christine Garnett, David G. Strauss, Norman Stockbridge, Marek Malik

SCIENTIFIC REPORTS (2019)

Article Pharmacology & Pharmacy

Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de Pointes

Lars Johannesen, Christine Garnett, Man Luo, Shari Targum, Jens Stampe Sorensen, Nitin Mehrotra

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

Review Pharmacology & Pharmacy

Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the CiPA Initiative and Design of a Prospective Clinical Validation Study

Jose Vicente, Robbert Zusterzeel, Lars Johannesen, Jay Mason, Philip Sager, Vikram Patel, Murali K. Matta, Zhihua Li, Jiang Liu, Christine Garnett, Norman Stockbridge, Issam Zineh, David G. Strauss

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

Article Cardiac & Cardiovascular Systems

Realtime Diagnosis from Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation with Long Follow-Up (REGAL): Rationale and design of a pragmatic, decentralized, randomized controlled trial

Xiaoxi Yao, Zachi I. Attia, Emma M. Behnken, Melissa S. Hart, Shealeigh A. Inselman, Kayla C. Weber, Fan Li, Nikki H. Stricker, John L. Stricker, Paul A. Friedman, Peter A. Noseworthy

Summary: This study aims to explore whether Apple Watch, used as a long-term monitoring device, is effective in the early diagnosis of atrial fibrillation (AF) and the prevention of cognitive function decline in older adults. By using AI-ECG to screen high-risk patients and record electrocardiograms, the effectiveness of Apple Watch will be evaluated. If successful, this approach could have significant implications on how future clinical practice leverages consumer devices for early diagnosis and disease prevention.

AMERICAN HEART JOURNAL (2024)